Safety and efficacy of a 6 French perclose arterial suturing device following percutaneous coronary interventions: A pilot evaluation

Ran Kornowski, Simcha Brandes, Igal Teplitsky, Eldad Rechavia, Nurit Shor, Alexander Battler, Abid Assali

Research output: Contribution to journalArticlepeer-review


Arterial access site management after percutaneous coronary intervention (PCI) is a matter of increasing importance in this era of potent antiplatelet pharmacotherapy. We evaluated the safety and efficacy of a 6 French (Fr) Perclose suturing device in achieving rapid hemostasis of the access site after PCI and thus improving patient comfort. Methods. The 6 Fr Perclose (Prostar) device consists of a suture-based closure device delivered via introducer sheath designed for suturing of the arteriotomy puncture site. Over a 3-month period, the device was used in 48 consecutive PCI treated patients (age, 62 ± 13 years; 70% male; 44% post myocardial infarction) and in-hospital groin complication rate was compared to 48 consecutive patients (age, 64 ± 12 years; 64% male; 33% post myocardial infarction) who had manual compression hemostasis. Results. Antiplatelet glycoprotein IIb/IIIa antagonists were used more frequently during and following the procedure in 58% of Perclose-treated patients versus 42% of the manual compression group (p = 0.019). Leg immobilization duration was 3-4 hours in all patients sutured by the device; in patients with manual compression, the sheath was removed at an average of 4.8 ± 2.5 hours after termination of the PCI and an additional 6 hours of leg immobilization were subsequently required. No difference in overall major complication rate was found between groups (6.2% in suture-mediated patients versus 9.3% in manual compression group; p = 0.60). In 3 patients (6.2%) treated using the device, adjunctive manual compression was required in addition to groin suturing due to technical failure or residual oozing from the arteriotomy site. Conclusion. The 6 Fr Perclose device can be safely used to achieve rapid hemostasis and the device may hasten bed mobilization of PCI-treated patients despite frequent use of potent antiplatelet pharmacotherapy during coronary interventions.

Original languageEnglish
Pages (from-to)741-745
Number of pages5
JournalJournal of Invasive Cardiology
Issue number12
StatePublished - Dec 2002


  • Closure device
  • Coronary angioplasty
  • Groin suturing


Dive into the research topics of 'Safety and efficacy of a 6 French perclose arterial suturing device following percutaneous coronary interventions: A pilot evaluation'. Together they form a unique fingerprint.

Cite this